Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-08-05
Summary
Main objective of this study is to describe the evolution of infusion settings (base, high and low infusion rates) of foslevodopa/foscarbidopa subcutaneous infusion (LDp/CDp) at different timepoints in the treatment of advanced Parkinson's disease (aPD) as captured in ONE-CRM.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-14
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Austria
- Netherlands
- Romania
- Sweden
Study Locations
More Related Trials
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
NCT03622905 ·Status: COMPLETED ·Phase: NA
-
A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
NCT03462043 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease
NCT00159172 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
STN-Stimulation Versus Best Medical Treatment in Advanced PD
NCT00196911 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient
NCT01274832 ·Status: UNKNOWN
-
Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease
NCT02539784 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Motor Inhibition in Parkinson's Disease and Focal Hand Dystonia
NCT05209516 ·Status: UNKNOWN ·Phase: NA
-
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
NCT06909045 ·Status: RECRUITING ·Phase: NA
-
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
NCT02615873 ·Status: UNKNOWN ·Phase: PHASE3
-
Motor Cortex Stimulation for Parkinson's Disease
NCT00637260 ·Status: COMPLETED ·Phase: NA
-
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
NCT01296464 ·Status: COMPLETED ·Phase: PHASE2
-
The Outcome of Subthalamic Deep Brain Stimulation in Advanced Parkinson's Disease and Morphometry
NCT06095245 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
NCT00134966 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
NCT00129181 ·Status: COMPLETED ·Phase: NA
-
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
NCT03517059 ·Status: COMPLETED
-
Electrophysiology-based DBS Programming for PD
NCT07348705 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Opicapone in Clinical Practice
NCT02847442 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study in Healthy Volunteers
NCT02554734 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
NCT05557864 ·Status: RECRUITING ·Phase: NA
-
Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease
NCT00358189 ·Status: COMPLETED
-
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
NCT00306124 ·Status: UNKNOWN ·Phase: PHASE4
-
Udall Project 2 Aim 2A&C
NCT05656586 ·Status: RECRUITING
-
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
NCT04990284 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
NCT02134795 ·Status: TERMINATED ·Phase: NA